A link between sudden, unexpected, infant deaths and inherited metabolic diseases was made almost 30 years ago,' but there has been increased interest in this topic recently.2 In particular, it has been claimed that an abnormality of fatty acid ,B-oxidation, medium chain acyl CoA dehydrogenase (MCAD) deficiency, could cause 3% of cases of sudden infant death syndrome (SIDS),3 and inherited metabolic diseases could account, in total, for about 10% of these deaths.4 However, these estimates were not based on systematic studies of SIDS cases and may not represent the true contribution that metabolic diseases make to the overall problem.
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Inherited metabolic diseases that are known to be associated with acute life threatening events are possible causes of SIDS. 4 The object of this study was to investigate all cases of sudden unexpected infant death within a defined geographical area over a two year period with a series of tests which should detect a large number of the relevant biochemical disorders.
Methods
During a period of two years, starting in May 1987, there were 109 babies who died suddenly and unexpectedly within Avon and north Somerset. Of these, 14 were excluded from the study because of late notification, but their omission was not considered to bias the composition of the group. The median age of the remaining 95 cases was 94 days (range 7-551) with a male to female distribution of 1-6:1. As part of the postmortem examination performed on these cases, an initial set of specimens, comprising body fluids and microbiological cultures, were obtained within a median time of 3-5 hours (range 0-25-46) from discovery of death. These specimens were processed for microbiological investigations immediately, and the remainder of the sample was frozen at -70°a nd stored for the biochemical tests. A skin biopsy specimen was taken for tissue culture and fibroblasts stored in liquid nitrogen at the second or third passage. There is a significant difference between the SIDS and MCAD deficiency cases for 4CO2 release from octanoate (p<0-01) and for the ratio of octanoate to butyrate oxidation (p<0 001).
tions of free and total carnitine were grossly raised in most samples compared with reference values for live babies of similar age, whereas the ratios of acyl to free carnitine were comparable. There was no apparent difference between the explained deaths and the SIDS cases. Table 3 gives the results of the skin fibroblast studies to diagnose MCAD deficiency. There was no difference between the results of 70 infants classified as SIDS and six in the explained death group. On the other hand, fibroblasts from four children not in the study, but diagnosed in our laboratory as having MCAD deficiency by GC/MS of urine and by other metabolic findings, showed a significant reduction in '4CO2 release with labelled octanoic acid as substrate. Table 3 shows a large standard deviation in all groups and there was an overlap in the distribution of the MCAD and the sudden death patients. However, this was due to a wide variation between batches in the assay, and within a batch patients with fatty oxidation defects were clearly differentiated.
Two livers have shown very striking panlobular microvesicular fatty changes comparable to those in Reye's syndrome, although no metabolic abnormality was found.
Discussion
Our investigation of organic acids in urine, cerebrospinal fluid, and vitreous humour in 94 cases of sudden infant death, including 88 with SIDS, failed to detect any abnormality. In addition, there was no indication of MCAD deficiency in the 70 SIDS cases in which it was looked for specifically using skin fibroblasts. A deficiency of MCAD can be diagnosed usually both by the urinary organic acid profile and by the skin fibroblast methods. In all, 69 SIDS patients had both types of investigation and showed a concurrence of negative results. An almost identical study to our own, on 105 cases of SIDS, also produced negative results.'0 The number of patients we investigated by TLC of amino acids was rather limited, but a published study of quantitative amino acid concentrations on the vitreous humour of 120 SIDS patients failed to find any disorder. '4 It has been suggested that the increase in serum carnitine observed in sudden infant death (table 2) is a postmortem change, because a correlation between carnitine concentration and the interval from estimated time of death to blood sampling has been found (P Divry, personal communication). Our data showed a similar tentative correlation. The estimated time of death was calculated as the mid-point in the time interval from when the baby was last known to be alive to when it was found dead. Babies were included in the analysis when this time interval was less than six hours (n=36). The correlation between the plasma free carnitine and the time from the estimated death to the blood sample being taken gave a linear regression equation, y=36-1+24-4x (r=0-61, p<0-001-). For plasma total carnitine the regression equation was y=914+25-7x (r=0-67, p<0 001). It seems probable that the postmortem rise in serum carnitine would mask a free carnitine deficiency that should indicate the presence of an organic aciduria. However, Since the completion of this study, interest was aroused by a report linking glucose-6-phosphatase deficiency (glycogen storage disease type 1, GSD 1) with sudden infant deaths.'8 One of the patients in our study was noted to have an unusually high lactic aciduria and abundant glycogen in the liver. This case has now been diagnosed as GSD Ic by A Burchell (personal communication) . Liver from all cases in our study has now been investigated for GSD 1, with a negative result.
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